| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |